Objectives: To characterize the genetic determinants responsible for extended-spectrum cephalosporin (ESC) resistance of D-tartrate-positive Salmonella enterica subsp. enterica serovar Paratyphi B (serovar Paratyphi B dT+) strains that have emerged in poultry and humans in Belgium during 2008 -10.
Introduction
Salmonella enterica subsp. enterica serovar Paratyphi B is responsible in humans for two different clinical syndromes: paratyphoid enteric fever and self-limited gastroenteritis. These two syndromes are generally caused by two different pathovars or biotypes, which have been differentiated on their capability to use D-tartrate as a carbon source, as suggested in the Kaufmann -White scheme. 1 The non-D-tartrate-fermenting variant (dT2, serovar Paratyphi B sensu stricto) usually provokes typhoid fever-like disease in humans only, whereas the D-tartrate-fermenting variant (dT+, formerly called serovar Java or variant Java and hereafter referred to as serovar Paratyphi B dT+) causes non-invasive gastroenteritis and is isolated from both humans and animals. Recently, the genetic relationships between Paratyphi B dT2 and this dT+ have been further studied by multilocus sequence typing (MLST) and this revealed that Paratyphi B dT2 is less diverse than dT+. 2 The variant dT+ is polyphyletic and distributed across unrelated eBurst groups. 2 Since the late 1990s, multidrug-resistant (MDR) isolates of serovar Paratyphi B dT+ have been increasingly isolated around the world.
Huehn et al. 3 showed that the population of serovar Paratyphi B dT+ is grouped in two major clonal lines that could be phenotypically differentiated by the expression of the O:5 antigen. Serovar Paratyphi B dT+ O:5 antigen-positive strains revealed a more diverse genetic background compared with the highly similar genetic background of serovar Paratyphi B dT+ O:5 antigen-negative strains. 3 Among the O:5 antigen-positive populations, strains that show different MDR phenotypes and diversity at the level of their genetic background have been found in Canada, France, the UK and Australia. 4 -8 These strains have been associated with human outbreaks due to contaminated alfalfa sprouts; home aquariums and their owners; tropical fish tanks; and travellers returning from South-East Asia. 4,6 -9 Most of these MDR serovar Paratyphi B dT+ O:5 antigen-positive strains contained the MDR Salmonella genomic island 1 (SGI1), or variants of it, responsible for various resistance phenotypes. 4, 7, 9 A distinct MDR serovar Paratyphi B dT+ clonal population is constituted of O:5 antigen-negative strains. This clone is regularly recovered in poultry production in Germany, the Netherlands and Belgium. 3, 10, 11 These strains are resistant to streptomycin, spectinomycin, sulphonamides and trimethoprim, and contain a chromosomally located class 2 integron with the dfrA1-sat2-aadA1 (Tn7) array of gene cassettes. 10, 11 In these three Western European countries, MDR serovar Paratyphi B dT+ continuously persists in poultry and is one of the most predominant serovars. Since the emergence of extended-spectrum cephalosporin (ESC) resistance in the early 2000s, only a few sporadic serovar Paratyphi B dT+ strains resistant to ESCs have been described to produce different extended-spectrum b-lactamases (ESBLs). 3,12 -14 Since 2008, an increasing number of serovar Paratyphi B dT+ strains have been isolated from poultry in Belgium. The remarkable change was the proportion of ESC-resistant strains that represented 35% in 2010. In the present study, we characterized the genetic determinants of ESC resistance among a representative set of serovar Paratyphi B dT+ strains isolated from broilers in Belgium in 2010. A few additional ESC-resistant serovar Paratyphi B dT+ strains isolated from human patients during the timeframe of increased incidence in poultry were also included. The aim of this study was to determine what were the most prevalent ESC resistance genes, to precisely identify their genetic supports and to determine at the epidemiological level whether these strains were clonal.
Materials and methods

Bacterial strains and antimicrobial susceptibility testing
Ninety-five non-redundant (one strain per serovar and per origin at the same sampling time) S. enterica serovar Paratyphi B dT+ O:5 antigennegative strains isolated from poultry from geographically distinct areas in Belgium in 2010 were initially studied at the CODA-CERVA for their susceptibility to 12 antibiotics. Among these representative strains, 35% were resistant to cephalosporins (Salmonella report 2010; http:// www.coda-cerva.be/index.php?option=com_content&view=article&id=121 &Itemid=286&lang=fr). Twenty-seven ceftiofur-resistant serovar Paratyphi B dT+ strains from poultry were used in this study. Retrospectively, the human serovar Paratyphi B dT+ strains received at the Belgian Scientific Institute of Public Health during the same period were screened for ESC-resistant strains and thus five additional human ESC-resistant strains were also included for comparison. All animal and human strains were tested for their antibiotic susceptibilities by the disc diffusion assay on Mueller-Hinton plates according to the guidelines of the Antibiogram Committee of the French Society for Microbiology, which implements EUCAST breakpoints. 15 Susceptibility to 30 antibiotics was determined using discs containing the following antibiotics: streptomycin, spectinomycin, gentamicin, kanamycin, amikacin, nalidixic acid, flumequine, ciprofloxacin, enrofloxacin, chloramphenicol, florfenicol, tetracycline, sulphonamides, trimethoprim, amoxicillin, amoxicillin/clavulanic acid, piperacillin, piperacillin/tazobactam, ticarcillin, ticarcillin/clavulanic acid, cefalotin, cefoxitin, cefuroxime, cefoperazone, ceftriaxone, ceftazidime, ceftiofur, cefepime, aztreonam and imipenem. All antibiotic discs except for florfenicol were purchased from Bio-Rad (Marnes-laCoquette, France). Florfenicol discs were obtained from Schering-Plough Animal Health (Kenilworth, NJ, USA).
Detection and sequencing of ESBL and AmpC genes, class 1 and class 2 integrons and MDR genomic island SGI1
In order to detect the presence of b-lactamases, PCR assays were performed to assess the presence of the bla TEM , bla SHV , bla CTX-M , bla VEB , bla DHA , bla ACC and bla CMY genes in the parental serovar Paratyphi B dT+ strains and in Escherichia coli transconjugants and/or transformants as previously described. 12 All PCR products obtained by amplification of bla TEM , bla CTX-M and bla CMY from serovar Paratyphi B dT+ strains were sequenced by Beckman Coulter Genomics (Grenoble, France). Sequence results were compared with those registered in databases.
The gene cassette array of class 1 and class 2 integrons was amplified from ESC-resistant serovar Paratyphi B dT+ strains and in E. coli transconjugants and/or transformants by using the CS1/CS2 and hep74/hep51 primers, respectively. 16, 17 Gene cassettes were identified by sequencing of PCR products. The presence or absence of SGI1 was assessed by PCR using primers previously described to amplify the left junction with the chromosome or the empty specific integration attB site at the 3 ′ end of the chromosomal gene trmE and the secondary attB site sodB-purR, respectively. 4, 9, 18 Transfer experiments and plasmid typing
Conjugative mating experiments were carried out in brain heart infusion broth with E. coli K-12 J53 (pro met azi) used as recipient strain and ESC-resistant serovar Paratyphi B dT+ donor strains in a 4 : 1 ratio. Transconjugants were selected on Salmonella-Shigella agar medium supplemented with ceftriaxone (2 or 64 mg/L) and sodium azide (500 mg/L). For unsuccessful conjugative transfer, the entire plasmid content of serovar Paratyphi B dT+ strains was electroporated into E. coli TOP10 (Life Technologies, Saint Aubin, France) as the recipient strain. ESC-resistant E. coli transformants were selected on Luria-Bertani (LB) agar supplemented with ceftriaxone (2 mg/L). ESC resistance-carrying plasmids were extracted from transconjugants/transformants using Macherey -Nagel NucleoBond Xtra Midi plasmid purification kit (Hoerdt, France) following the manufacturer's recommendations for high molecular weight plasmids. In order to characterize plasmids containing b-lactamase genes, plasmid incompatibility groups were determined using the PCR-based replicon typing (PBRT) method. 19 Subtyping of IncI1 and IncHI2 plasmids was performed using plasmid MLST (pMLST). 20, 21 Plasmids were further Doublet et al.
compared using restriction fragment length polymorphism (RFLP) analysis with PstI or EcoRI restriction enzymes.
Molecular typing of the genetic background
ESC-resistant serovar Paratyphi B dT+ strains were investigated by PFGE using the Pulsenet protocol (http://www.cdc.gov/pulsenet/PDF/ecolishigella-salmonella-pfge-protocol-508c.pdf). MLST was performed on seven gene fragments using the amplification and sequencing primers that are described on the MLST web site (http://mlst.ucc.ie/mlst/dbs/ Senterica/documents/primersEnterica_html), taking into account the update information for 24 August 2005. (Table 1) . Group 1 contained 19 strains resistant to ceftriaxone and ceftiofur but susceptible to cefoxitin, showed clavulanic acid inhibition of their b-lactamases and gave a positive ESBL synergy test. Among them, five strains (group 1a) were also resistant to ceftazidime and cefepime, while the 14 remaining strains (group 1b) showed intermediate resistance to ceftazidime and cefepime. Group 2 contained eight other ESC-resistant strains that were fully resistant to amoxicillin + clavulanic acid, cefoxitin and ceftazidime. Among these, two strains (group 2a) were also fully resistant to ceftriaxone and cefepime, whereas the six remaining strains (group 2b) showed a lower level of resistance to ceftriaxone than to ceftazidime and remained susceptible to cefepime. None of the strains was resistant to imipenem. On this basis, various ESBLs and/or AmpCs were suspected. Different additional non-b-lactam resistance phenotypes were found against aminoglycosides, sulphonamides, trimethoprim, tetracycline and quinolones among ESC-resistant serovar Paratyphi B dT+ strains (Table 1) .
Detection and transfer of ESBL and AmpC resistance genes
Among these ESC-resistant serovar Paratyphi B dT+ strains, the following ESBL/AmpC genes were found in correlation with the phenotypic b-lactam resistance groups defined earlier: group 1a strains carried the ESBL gene bla CTX-M-2 and the narrow-spectrum b-lactamase gene bla TEM-1 (4 strains) or bla TEM-52c alone (1 strain); in group 1b, all the strains contained the ESBL gene bla CTX-M-1 alone (14 strains) ( Table 1 ). All the strains of group 2 contained the AmpC cephalosporinase gene bla CMY-2 and the two strains highly resistant to all cephalosporin generations (group 2a) carried in addition the ESBL gene bla CTX-M-2 and the narrow-spectrum b-lactamase gene bla TEM-1 (Table 1) .
Twenty-five strains of 27 were able to transfer their ESC resistance phenotype to the E. coli recipient strain, with two isolates unable to transfer bla CTX-M-1 . All transconjugants obtained from a parental serovar Paratyphi B dT+ strain containing only one ESBL or AmpC gene showed the corresponding phenotypic b-lactam resistance profile from the parental strain. The conjugative transfer of the ESBL genes bla CTX-M-1 (12 strains), bla CTX-M-2 (4 strains) and bla TEM-52c (1 strain) and the AmpC gene bla CMY-2 was confirmed by PCR and sequencing in all transconjugants ( Table 1) . The narrow-spectrum b-lactamase gene bla TEM-1 was co-transferred with the ESBL gene bla CTX-M-2 in all transconjugants tested (six strains) (Table 1 ). However, for the serovar Paratyphi B dT+ strains 2010/10841 and 2010/01029, containing both the ESBL gene bla CTX-M-2 and the AmpC gene bla CMY-2 , the great majority of transconjugants showed an AmpC phenotype with a higher resistance level to ceftazidime than to ceftriaxone, were cefepime susceptible and harboured bla CMY-2 . A smaller number harboured both bla CTX-M-2 and bla CMY-2 and were additionally resistant to cefepime. To isolate transconjugants carrying only the bla CTX-M-2 plasmid from serovar Paratyphi B dT+ strains 2010/10841 and 2010/01029, selection on 64 mg/L ceftriaxone was needed, although even here the majority harboured both bla CTX-M-2 and bla CMY-2 . Few transconjugants contained only the ESBL gene bla CTX-M-2 and the bla TEM-1 gene.
Finally, the entire plasmid content of the two strains that were unable to conjugate their ESC phenotype were electroporated into E. coli TOP10. ESC-resistant transformants were selected on LB plates supplemented with ceftriaxone at 2 mg/L. All transformants tested showed an ESBL phenotype and were positive for bla CTX-M-1 (Table 1) .
In all transconjugants or transformants, different additional non-b-lactam resistance phenotypes were also transferred, depending on the ESBL or AmpC genes, and also from the parental serovar Paratyphi B dT+ strains (Table 1 ).
Molecular plasmid typing
PBRT indicated that all bla CTX-M-1 genes and bla CMY-2 genes were located on IncI1 plasmids (Table 1) . 19 According to the pMLST scheme (http://pubmlst.org/plasmid/), bla CTX-M-1 -carrying IncI1 plasmids belonged to different sequence types (STs): ST3, an ST of the clonal complex (CC) CC-3, and ST7 and ST15, which are member of CC-7 (Table 1) . bla CTX-M-1 -carrying IncI1 plasmids conferred resistance to non-b-lactam antibiotics, varying from no additional resistance, resistance to sulphonamides and resistance to sulphonamides and trimethoprim (Table 1 ). All bla CMY-2 -carrying IncI1 plasmids belonged to ST12 (CC-12) (Table 1) , which is not related to CC-3 or CC-7 (pMLST; http://pubmlst.org/plasmid/). These bla CMY-2 -carrying IncI1/ST12 plasmids did not confer additional resistances (Table 1) . Typically, the bla TEM-52c -carrying IncI1 plasmid was from ST36 (CC-5) and only conferred the ESBL resistance phenotype (Table 1) .
Plasmids carrying both bla CTX-M-2 and bla TEM-1 were all typed by PBRT as multireplicon plasmids IncHI2/P ( Table 1 ). The doublelocus sequence subtyping scheme for IncHI2 plasmids demonstrated that all belonged to ST2. Plasmids carried additional resistances to sulphonamides, tetracycline and trimethoprim (Table 1) .
PstI restriction analysis on IncI1 plasmids demonstrated that ST grouping with CC-7 [ST7 and ST15 (bla CTX-M-1 )] showed the most diversity, and IncI1/ST3 (bla CTX-M-1 ) and IncI1/ST12 (bla CMY-2 ) plasmids the least (Figure 1a) . Similarly, bla CTX-M-2 multireplicon IncHI2/ P plasmids displayed a closely related EcoRI restriction profile (Figure 1b) .
Class 1 and class 2 integron gene cassette arrays and SGI1 detection
All ESC-resistant serovar Paratyphi B dT+ strains were positive for a class 2 integron and yielded a 2300 bp PCR product. Sequence analysis of this PCR product revealed the presence of the same three cassettes as those found in Tn7, namely dfrA1-sat2-aadA1. This class 2 integron gene cassette array could not be detected in ESC-resistant E. coli transconjugants. Thirteen of the ESC-resistant serovar Paratyphi B dT+ strains were also positive for a class 1 integron. One strain carried a class 1 integron with a variable region of 1000 bp corresponding to a resistance gene cassette fusion between aadA13 and aadA1 ( Table 1 ). An 2000 bp cassette array was amplified for another strain containing the resistance gene cassettes aadA2 and lnuF (lincosamide resistance). The 11 other strains contained a class 1 integron gene cassette array dfrA1-aadA1 (1600 bp) that was located on all bla CTX-M-2 multireplicon IncHI2/P plasmids and on the unique bla CTX-M-1 -carrying IncI1/ ST15 plasmid, and the four remaining integrons (dfrA1-aadA1) were not transferred with the ESC resistance. Surprisingly, all E. coli transconjugants positive for the dfrA1-aadA1 cassette array remained susceptible to streptomycin and spectinomycin for an unknown reason. All ESC-resistant serovar Paratyphi B dT+ strains were negative for SGI1 and showed empty attB integration sites.
4,9,18
ESC-resistant serovar Paratyphi B dT1 from human patients
In 2009 and 2010, an increased proportion of Salmonella isolates from humans in Belgium were of serovar Paratyphi B dT+ [73/ 3208 (2.3%) and 42/3660 (1.1%), respectively, compared with ,0.7% in previous years]. Ten of these were ESC resistant but only five strains were stored and thus included in the present study. The isolates were positive for the chromosomal 2300 bp class 2 integron cassette array dfrA1-sat2-aadA1 and negative for SGI1. All strains showed ESBL phenotypes that were confirmed by the presence of bla CTX-M-2 in four strains and bla TEM-52c in one strain (Table 1) . Conjugative transfer of ESC resistance was performed to the E. coli recipient strain. Plasmid typing revealed the presence of the bla CTX-M-2 genes on conjugative multireplicon IncHI2/P plasmids in four human strains (three conjugative and one non-conjugative; Table 1 ). The ESBL gene bla TEM-52c was located on a conjugative IncI1 plasmid also found in poultry strains (Table 1) .
Genetic background of ESC-resistant serovar Paratyphi B dT1 strains
The genetic relationship between strains was studied by PFGE and MLST on a subset of representative strains of broiler and human origin. PFGE using XbaI showed that all ESC-resistant serovar Paratyphi B strains isolated from broilers and humans had the typical XbaI PFGE pattern X8 previously described (data not shown). 10,11,13 A few differences in smaller band patterns (,100 kb) were noted between strains, and are probably related to differences in the plasmid content, i.e. bla CTX-M-2 -carrying IncHI2/P plasmid and other ESBL IncI1 plasmids (data not shown). MLST was performed on these representative strains. All strains tested belonged to ST28 in eBurst group 59, as previously described for the European poultry-associated serovar Paratyphi B dT+ clonal population that has spread since the late 1990s. 2 
Discussion
Serovar Paratyphi B dT+ has recently become one of the most frequently isolated serovars in European broiler flocks, especially in the Netherlands, Belgium and Germany, indicating a good adaptation of this serovar to poultry. 22 This distinct poultry-associated MDR clone was characterized at the molecular level in the early 2000s and revealed a highly similar genetic background.
3,10,11 A peculiar phenotypic property of this MDR clone is the absence of the O:5 antigen. 3 Moreover, European O:5 antigen-negative poultry-associated serovar Paratyphi dT+ strains contain a chromosomally located class 2 integron with dfrA1-sat2-aadA1 resistance gene cassettes conferring resistance to trimethoprim, streptothricin, streptomycin and spectinomycin. Occasionally, they possess in addition a class 1 integron with the drfA1-aadA1 resistance gene cassettes.
10 All strains also exhibit the unique XbaI PFGE pattern X8.
3,10,11, 13 The highly similar genetic background of the European poultry-associated serovar Paratyphi dT+ clone has been also confirmed by MLST, which grouped all strains into a single ST (ST28). 2 In the present study, we report an increase of ESC-resistant strains among serovar Paratyphi B dT+ isolates from Belgian broilers since 2009. In 2010, the most prevalent ESBLs were CTX-M-1 and CTX-M-2, as well as the AmpC cephalosporinase CMY-2. During the same period, the Belgian Salmonella reference laboratory detected a few human cases infected by ESC-resistant (carrying CTX-M-2 or TEM-52) strains of this poultry-associated serovar.
Molecular characterization of ESC resistance showed that the two main subtypes of bla CTX-M-1 -carrying IncI1 plasmids disseminated among serovar Paratyphi B dT+ strains from broilers are: (i) closely related bla CTX-M-1 -carrying IncI1/ST3 plasmids that might be highly similar to other epidemic bla CTX-M-1 -carrying IncI1/ST3 plasmids also detected from a wide range of animal species in Europe and North Africa, 23 -27 and (ii) highly related bla CTX-M-1 -IncI1/CC-7 plasmids (ST7 and ST15) that successfully spread among different E. coli and S. enterica serovars from poultry and humans in the Netherlands. 28 The multireplicon IncHI2/P plasmids carrying bla CTX-M-2 were also found in poultry-associated serovar Paratyphi B dT+ in Belgium. These plasmids also contained a narrow-spectrum bla TEM-1 gene. Similar high molecular weight ( 340 kb) multireplicon IncHI2/P plasmids have been also described in serovar Paratyphi B dT+ strains isolated from poultry in the Netherlands, in serovar Virchow strains previously isolated from poultry in Belgium and in E. coli isolated from diseased horses in Belgium. 14, 29, 30 Interestingly, these bla CTX-M-2 -multireplicon IncHI2/P plasmids possessed a class 1 integron with the drfA1-aadA1 resistance gene cassette array that has been described before on large plasmids from poultry-associated serovar Paratyphi B strains. 10 Although the functionality of the replicons remains to be established, such plasmids in general combine a broad host range and transfer and maintenance abilities that probably contribute to the persistence and dissemination of these bla CTX-M-2 -carrying plasmids. 
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In the present work, only two strains contained bla TEM-52 that was located on an IncI1/ST36 plasmid. This is consistent with previous studies where bla TEM-52 has been found on IncI1 plasmids from CC-5 (ST10 and ST36) in E. coli and Salmonella isolated from chicken meat, poultry, cattle and humans from Western Europe. 28, 31, 32 Finally, very closely related IncI1/ST12 plasmids carrying bla CMY-2 were found in a poultry-associated serovar Paratyphi B dT+ clonal population in Belgium. These bla CMY-2 -IncI1/ST12 plasmids have previously been identified in other S. enterica serovars in the USA from human sources. 33, 34 Recently, IncI1/ST12 plasmids carrying bla CMY-2 were detected in E. coli from poultry in Tunisia and Europe. 26, 34, 35 IncI1/ST12 plasmids of serovar Paratyphi B strains in our study might be highly related to other globally diffused epidemic plasmids. 26,33 -35 Fine molecular typing of ESBL plasmids by PBRT, pMLST and RFLP allowed us to demonstrate the dissemination of highly related ESBL/AmpC plasmids in different bacterial genetic backgrounds from various sources (animals and humans) and from different geographical regions. 30,33 -35 These findings show the enormous impact of such promiscuous plasmids. It indicates that the fight against antimicrobial resistance should also include the thorough study of plasmids and a better understanding of their epidemiology in order to be able to intervene at the level of spread of plasmids.
Before 2007, ESC resistance among Paratyphi B dT+ from poultry had only been sporadically reported and consisted of a few isolates producing CTX-M-1, CTX-M-2, TEM-52 and TEM-20.
3,12 -14 Thus, this report indicates a worrisome trend of increasing prevalence of these strains in poultry since 2007. The genetic background of Paratyphi B dT+ has been studied recently and a unique human serovar Paratyphi B dT+ strain that carries bla TEM-52 (IncI1 plasmid, 80 kb), found in Germany, showed an identical XbaI PFGE pattern to the TEM-52-producing serovar Paratyphi B dT+ strains from poultry, previously described. 36 The number of serovar Paratyphi B dT+ showing resistance to clinically important antimicrobials (extended-spectrum b-lactams) seems to be increasing all over Europe and is mainly associated with poultry. The presence of additional resistance genes for sulphonamides, tetracycline and trimethoprim on the ESBL-carrying plasmids and the cross-resistance to penicillin antibiotics may result in a large selection of ESBL genes, since these drugs are frequently used in poultry production. 37 
Concluding remarks
Since 2009, the prevalence of serovar Paratyphi B dT+ has increased substantially among poultry in Belgium. Around 30% of serovar Paratyphi B dT+ strains are ESC resistant. The ESBLs CTX-M-1 and CTX-M-2, and the AmpC cephalosporinase CMY-2, seem to be the most prevalent. A few different conjugative IncI1 plasmids and IncHI2/P plasmids are responsible for this spread among MDR serovar Paratyphi B dT+ O:5 antigen-negative strains in poultry in some Western European countries (Belgium, Germany and the Netherlands). Future studies should focus on how some emerging successful MDR mobile genetic elements become dominant in different foodborne pathogens and on understanding their evolutionary success. However, prudent and rational use of all antimicrobial classes in poultry is necessary to avoid their further dissemination among other Salmonella serovars or bacterial species.
